Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=40203031&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP056216(A)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biovail Lab Int SrlfiledCriticalBiovail Lab Int Srl
Priority to ECSP056216priorityCriticalpatent/ECSP056216A/en
Publication of ECSP056216ApublicationCriticalpatent/ECSP056216A/en
Una tableta de liberación modificada de clorhidrato de bupropion, que comprende (i) un núcleo que comprende una cantidad efectiva de clorhidrato de bupropion, un aglutinante, un lubricante y (ii) un recubrimiento para controlar la liberación que rodea el núcleo y (iii) una barrera contra la humedad que rodea el recubrimiento para controlar la liberación, en done la tableta de liberación modificada es bioequivalente a las tabletas de Wellbutrin® o de Zyban®/Wellbutrin®SR.A modified release tablet of bupropion hydrochloride, comprising (i) a core comprising an effective amount of bupropion hydrochloride, a binder, a lubricant and (ii) a coating to control the release surrounding the core and (iii) a moisture barrier surrounding the coating to control release, where the modified-release tablet is bioequivalent to Wellbutrin® or Zyban® / Wellbutrin®SR tablets.
COMPOUNDS DERIVED FROM PIRROLO PIRIDINA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE FOR THE TREATMENT OF THE DISEASE OF ALZHEIMER, PARKINSON, CANCER, AMONG OTHER ILLNESSES.
USE OF A COPOLIMERO OF (MET) ANIONIC ACRYLATE, PARTLY NEUTRALIZED, AS A COVER FOR THE PRODUCTION OF A PHARMACEUTICAL FORM THAT RELEASES ACTIVE SUBSTANCE WITH REDUCED PH VALUES.
COMPOUNDS DERIVED FROM DIHIDRO AND TETRAHIDRO OXAZOLOPIRIMIDINONAS REPLACED; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE FOR THE TREATMENT OF CHICHOPHRENIA, EPILEPSY, BETWEEN OTHER DISEASES.
COMPOUNDS DERIVED FROM PYRIDOPIRIMIDINONES; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT PAIN, DEPRESSION, CARDIOVASCULAR DISEASES, RESPIRATORY DISEASES AND PSYCHIATRIC DISEASES.
Pharmaceutical composition comprising 100 to 2000 mg of metformin and 10 to 300 mg of a glucopyranosyl substituted phenyl derivative sglt-2 inhibitor compound, microcrystalline cellulose, a binder and croscarmellose.
COMPOSITION THAT INCLUDES AT LEAST AN IRONING COMBINING COMPOUND AND AT LEAST AN ANTIFUNGIC AGENT; AND METHOD FOR THE TREATMENT OR PREVENTION OF A FUNGICAL CONDITION.
METHOD FOR THE TREATMENT OF OCULAR HYPERTENSION THAT INCLUDES A SMALL MOLECULA AGENT THAT INTERACTS WITH A CODIFYING GENE FOR SERICA AMYLOID PROTEIN A (SAA).
Compounds derived from heterocycles; its preparation process; fungicidal composition comprising said compounds; and method to combat or control phytopathogenic fungi.
Compounds derived from alkylheterocycles carbamates; preparation procedure; pharmaceutical composition; and its use to prevent or treat acute or chronic pain, neurological and psychiatric pathologies, cardiovascular diseases, among others.